HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

California May Limit Prop 65 Short-Form Warnings To Packages Short On Space

Executive Summary

California may move to limit when Prop 65 stakeholders can use short-form warnings on products instead of longer-form warnings because firms are opting for the shorter warnings at an unexpected rate. Manufacturers may be leaning on the short-form too much for the state's taste and to the surprise of food and drug lawyers.

You may also be interested in...



US Wellness Market In 2019: Amarin Wins, Loses On Supplements; Gottlieb Leaves With Consumer Health Flourish

Looking look back on US wellness market developments and events in 2019, HBW Insight finds a firm that doesn’t compete in the dietary supplement sector, Amarin, made a good bit of news that affected the industry during the year. We track news across the wellness space from the past year.

Prop 65 Proposal Stirs Retailers To Request Manufacturers' Guarantees

California Prop 65 amendment has retailers asking manufacturers for unrealistic guarantees that no products contain any Prop 65 chemicals, says Clif Bar & Co. Chief Counsel Amy Norris. Manufacturers should develop standard response to retailers' myriad requests and develop a plan to address any issues that could arise.

Prop 65 Labeling Exemption Degree Of Difficulty Higher In Proposed Amendment

California's proposed Prop 65 changes would impact how supplement and food manufacturers and other firms test samples of products and how they calculate the “average” rate of human exposure to a substance, says food and drug attorney George Gigounas.

Related Content

Topics

UsernamePublicRestriction

Register

RS148597

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel